Cargando…

Impact of metabolic control on macular thickness in diabetic macular oedema

PURPOSE: To investigate the impact of metabolic control on macular thickness measured using optical coherence tomography in patients with diabetic retinopathy with or without macular oedema. METHODS: A total of 124 patients with diabetic retinopathy (n = 70 without macular oedema and n = 54 with mac...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yi-Jie, Tsai, Meng-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818022/
https://www.ncbi.nlm.nih.gov/pubmed/29212365
http://dx.doi.org/10.1177/1479164117746023
_version_ 1783300961930838016
author Peng, Yi-Jie
Tsai, Meng-Ju
author_facet Peng, Yi-Jie
Tsai, Meng-Ju
author_sort Peng, Yi-Jie
collection PubMed
description PURPOSE: To investigate the impact of metabolic control on macular thickness measured using optical coherence tomography in patients with diabetic retinopathy with or without macular oedema. METHODS: A total of 124 patients with diabetic retinopathy (n = 70 without macular oedema and n = 54 with macular oedema) were enrolled. Optical coherence tomography parameters measured included central macular thickness and total macular volume. Metabolic factors with correlation to optical coherence tomography parameters were fasting plasma glucose, glycosylated haemoglobin, triglyceride, low-density lipoprotein and estimated glomerular filtration rate. Multiple linear regression models were used to evaluate associations between optical coherence tomography parameters and metabolic factors. RESULTS: Higher glycosylated haemoglobin values were correlated with increased central macular thickness in patients without macular oedema (R = 0.289, p = 0.015), whereas glycosylated haemoglobin values were inversely associated with central macular thickness in patients with macular oedema (R = –0.374, p = 0.005). Both were found to be statistically significant after adjusting for age, sex and diabetic retinopathy severity in addition to other metabolic factors (p = 0.009 and p = 0.002, respectively). CONCLUSION: Strict metabolic control may not be associated with better macular thickness in diabetic patients with co-existing macular oedema.
format Online
Article
Text
id pubmed-5818022
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-58180222018-03-01 Impact of metabolic control on macular thickness in diabetic macular oedema Peng, Yi-Jie Tsai, Meng-Ju Diab Vasc Dis Res Brief Reports PURPOSE: To investigate the impact of metabolic control on macular thickness measured using optical coherence tomography in patients with diabetic retinopathy with or without macular oedema. METHODS: A total of 124 patients with diabetic retinopathy (n = 70 without macular oedema and n = 54 with macular oedema) were enrolled. Optical coherence tomography parameters measured included central macular thickness and total macular volume. Metabolic factors with correlation to optical coherence tomography parameters were fasting plasma glucose, glycosylated haemoglobin, triglyceride, low-density lipoprotein and estimated glomerular filtration rate. Multiple linear regression models were used to evaluate associations between optical coherence tomography parameters and metabolic factors. RESULTS: Higher glycosylated haemoglobin values were correlated with increased central macular thickness in patients without macular oedema (R = 0.289, p = 0.015), whereas glycosylated haemoglobin values were inversely associated with central macular thickness in patients with macular oedema (R = –0.374, p = 0.005). Both were found to be statistically significant after adjusting for age, sex and diabetic retinopathy severity in addition to other metabolic factors (p = 0.009 and p = 0.002, respectively). CONCLUSION: Strict metabolic control may not be associated with better macular thickness in diabetic patients with co-existing macular oedema. SAGE Publications 2017-12-07 2018-03 /pmc/articles/PMC5818022/ /pubmed/29212365 http://dx.doi.org/10.1177/1479164117746023 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Brief Reports
Peng, Yi-Jie
Tsai, Meng-Ju
Impact of metabolic control on macular thickness in diabetic macular oedema
title Impact of metabolic control on macular thickness in diabetic macular oedema
title_full Impact of metabolic control on macular thickness in diabetic macular oedema
title_fullStr Impact of metabolic control on macular thickness in diabetic macular oedema
title_full_unstemmed Impact of metabolic control on macular thickness in diabetic macular oedema
title_short Impact of metabolic control on macular thickness in diabetic macular oedema
title_sort impact of metabolic control on macular thickness in diabetic macular oedema
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818022/
https://www.ncbi.nlm.nih.gov/pubmed/29212365
http://dx.doi.org/10.1177/1479164117746023
work_keys_str_mv AT pengyijie impactofmetaboliccontrolonmacularthicknessindiabeticmacularoedema
AT tsaimengju impactofmetaboliccontrolonmacularthicknessindiabeticmacularoedema